Drug ID: | NPD7237 |
Drug Name: | |
Molecular Formula: | C29H33NO12 |
Canonical SMILES: | COc1cc(cc(c1O)OC)[C@H]1[C@H]2C(=O)OCC2C(c2c1cc1OCOc1c2)OC1OC2COC(OC2C(C1N)O)C |
Standard InCHI: | InChI=1S/C29H33NO12/c1-11-36-9-20-27(40-11)25(32)23(30)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)24(31)19(5-12)35-3/h4-7,11,15,20-23,25-27,29,31-32H,8-10,30H2,1-3H3/t11?,15?,20?,21-,22+,23?,25?,26?,27?,29?/m1/s1 |
Standard InCHIKey: | FBXXLRBLSSYWAA-WXRMPKHTSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB002485 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 587.20 |
ALogP | -2.8599 |
MLogP | 3.22 |
XLogP | 0.132 |
HDA | 8 |
HBD | 3 |
Rotatable Bonds | 11 |
TPSA | 166.62 |
RO5 Violation | 0 |